University of Nebraska, Lincoln and Medical Center: Research to Revenue

University of Nebraska, Lincoln and Medical Center

Summit Venture Studio

Research to Revenue Report

Summit Venture Studio (SVS) Opportunities

SVS has identified 23 commercialization opportunities from University of Nebraska, Lincoln and Medical Center and scored them based on our proprietary metrics and rubrics.

The SVS model is to identify the top 1% of commercialization opportunities and start companies around them.

Please connect with SVS if you would like to engage with us in our startup and investment efforts.

Return on Research (ROR) Analysis

Commercialization Revenue per Research Dollar

Top Universities by Return on Research (ROR)

ROI Ratio: Commercialization Revenue ÷ Research Funding

University Innovation Analysis

Total Innovation Scores by Institution

Top Universities by Innovation Score

180+ High Innovation

150-179 Strong Innovation

130-149 Moderate Innovation

100-129 Emerging Innovation

130+ total score considered high innovation impact

SVS Innovation Index

Proprietary Assessment of University of Nebraska, Lincoln and Medical Center's Innovation Ecosystem
Score out of 100. Benchmark: Top 50 U.S. research institutions.
A score of 90/100 can be read "doing better than 90% of schools benchmarked"

Innovation Visibility

51/100

Definition: Media mentions, publication count, and global research visibility metrics

Startup Momentum

7/100

Definition: Growth in patents, funding, and startup formation

Ecosystem Strength

62/100

Definition: Tech transfer infrastructure and support systems

Innovation Legacy

A Timeline of Groundbreaking Discoveries

Innovation Timeline

Founded

1869

First Nobel

1972

First Patent

1975

First IPO

1995

2022-2024

AI-powered diagnostics

2025

Today

Notable Commercialization Outcomes

Nobel Prizes

1960s

Invention Disclosure

First patent filed

1960s

Patent Granted

Hybrid seed patent

1971

Startup Launch

First biotech company

1980s

License Agreement

Pharmaceutical licensing deal

1995

Research Collaboration

Industry partnership formed

2005

Competitive Benchmarking

University of Nebraska, Lincoln and Medical Center vs. Peer Research Universities

University of Nebraska, Lincoln and Medical Center vs Peers Comparison

Metric	University of Nebraska, Lincoln and Medical Center (FY2023)	Peer Average	Elite Average
Annual R&D Expenditure	$617M	$855M	$1,675M
New Inventions Disclosed	50	200	400
Startups Formed	3	7	10
Visibility Index	12	12	23
Licensing Revenue	$5M	$17M	$46M

Note: Peer Average = Median value among U.S. R1 research universities. Elite Average = Top 10 ranked U.S. research universities.

Emerging Opportunities

1. AI-Driven Cancer Diagnostics Revolutionizing Early Detection and Treatment

Advanced AI algorithms improve accuracy and speed in cancer diagnosis, enabling earlier interventions, reducing costs, and enhancing patient survival rates globally.

2. Precision Agriculture Technologies Enhancing Crop Yields and Sustainability

Innovative sensor and data analytics solutions optimize farming practices, increase productivity, reduce resource waste, and support sustainable food production at scale.

3. Biodegradable Polymers Transforming Medical Implant Industry

Novel biodegradable polymers offer safer, customizable medical implants that reduce complications, promote healing, and cater to growing global demand in healthcare.

4. Nanotechnology-Based Drug Delivery Systems Improving Therapeutic Outcomes

Targeted nanocarriers increase drug efficacy and reduce side effects, addressing critical challenges in chronic disease treatments with scalable pharmaceutical applications.

5. Renewable Energy Storage Solutions Enabling Grid Stability and Efficiency

Advanced battery technologies provide scalable, cost-effective energy storage, supporting renewable integration and solving intermittency issues in global power grids.

6. Telehealth Platforms Expanding Access to Rural and Underserved Populations

Secure, user-friendly telemedicine systems bridge healthcare gaps, improving patient outcomes and reducing costs in remote and resource-limited communities worldwide.